
Overview
Board certified in radiation oncology, Matthew Manning, MD, balances his leadership and clinical responsibilities with clinical interest in prostate, bladder, brain and spine, melanoma and thoracic cancers.
His research on high-tech therapies, including stereotactic radiosurgery and brachytherapy, has helped elevate Cone Health’s cutting-edge clinical care at national meetings. In recent years, he has been published in the Journal of Applied Clinical Medical Physics and International Radiation Oncology Biology and Physics. In 2016, he received the Association of Community Cancer Centers’ Innovator Award. In collaboration with the Greensboro Health Disparities Collaborative, he has also co-authored studies to eliminate racial disparity in cancer care.
Married with three children, he enjoys live music, going to the gym and traveling.
Dr. Manning is rated as an Experienced provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Prostate Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 W Friendly Ave, Greensboro, NC 27403
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center
As a radiation oncologist, I treat adults and children with sarcomas and other conditions of the musculoskeletal system. In my practice, we recognize that a cancer diagnosis affects the entire family and work to care for all members. Our team is committed to offering personalized, multi-disciplinary care. Dr. Larrier is rated as a Distinguished provider by MediFind in the treatment of Fibrosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, and Rhabdomyosarcoma.
David Kirsch is a Radiation Oncologist in Durham, North Carolina. Dr. Kirsch is rated as an Elite provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma, and Melanoma of the Eye. Dr. Kirsch is currently accepting new patients.
Joel Tepper is a Radiation Oncologist in Chapel Hill, North Carolina. Dr. Tepper is rated as an Advanced provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Primitive Neuroectodermal Tumor (PNET).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Manning isDistinguished. Learn about Familial Prostate Cancer.
- Pleuropulmonary BlastomaDr. Manning isDistinguished. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Manning isDistinguished. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Manning isDistinguished. Learn about Primitive Neuroectodermal Tumor (PNET).
- Prostate CancerDr. Manning isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Manning isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerDr. Manning isAdvanced. Learn about Breast Cancer.
- Lung CancerDr. Manning isAdvanced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Manning isAdvanced. Learn about Metastatic Brain Tumor.
- Muscle Invasive Bladder CancerDr. Manning isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Manning isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Manning isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Manning isExperienced. Learn about Anal Cancer.
- AstrocytomaDr. Manning isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Manning isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Manning isExperienced. Learn about Brain Tumor.
- Cervical CancerDr. Manning isExperienced. Learn about Cervical Cancer.
